Comparison of Bioavailability of Single ‐Dose Extended‐Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery

ConclusionThis study suggests that RYGB does not significantly alter the amount of venlafaxine or its active metabolite, ODV, absorbed from a venlafaxine ER capsule or the time over which it is absorbed.This article is protected by copyright. All rights reserved.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - August 28, 2017 Category: Drugs & Pharmacology Authors: Carrie A. Krieger, Julie L. Cunningham, Karen B. Grothe, Joel M. Reid, Loralie J. Langman, Matthew M. Clark, Ross A. Dierkhising Tags: Original Research Article Source Type: research